Overview

Topical Aluminium Chloride vs OnabotulinumtoxinA Intradermal Injections in Residual Limb Hyperhidrosis (Lower Limbs)

Status:
Completed
Trial end date:
2021-03-03
Target enrollment:
Participant gender:
Summary
The aim of this study is to demonstrate onabotulinumtoxinA superiority to aluminium chloride for the treatment of residual limb hyperhidrosis.
Phase:
Phase 3
Details
Lead Sponsor:
Direction Centrale du Service de Santé des Armées
Treatments:
abobotulinumtoxinA
Aluminum chloride
Botulinum Toxins, Type A
onabotulinumtoxinA